Skip to main content

AusPAR: Rivaroxaban

Australian Public Assessment Report
Device/Product Name
Xarelto
Active ingredients
Rivaroxaban
AusPAR Date
Published
Submission Number
PM-2017-04819-1-3
Submission Type
Extension of indications new dosage
Decision
Approved

Help us improve the Therapeutic Goods Administration site